ZFHN Zukunftsfonds Heilbronn

ZFHN Zukunftsfonds Heilbronn is a venture capital firm based in Heilbronn, Germany, established in 2005. The firm focuses on supporting young, innovative technology companies, particularly in the MedTech, BioTech, and Cleantech sectors, that are located in or planning to establish themselves in the Heilbronn region. ZFHN is privately financed with equity capital in the three-digit million range and aims to develop Heilbronn into a successful technology hub by fostering the growth of these industries.

The firm's investment strategy involves providing capital, expertise, and connections to companies at various stages, from seed to expansion. ZFHN operates as a long-term entrepreneurial partner, with investment periods of up to 15 years, assisting companies from the seed phase through startup and expansion stages. The firm also focuses on building and expanding clusters in MedTech, BioTech, and Cleantech within the region.

Over the years, ZFHN has been involved in several significant investments and exits, contributing to the growth and development of the technology sector in Heilbronn. The firm's portfolio includes companies such as Xenios AG, a medical technology company acquired by Fresenius Medical Care in 2016, and Enymotion GmbH, a company that secured funding from ZFHN and High-Tech Gründerfonds in 2023. These investments highlight ZFHN's commitment to supporting innovative companies and enhancing the technological landscape of the region.